Shedding light on therapeutics in alopecia and their relevance to COVID-19.
Identifieur interne : 000010 ( Main/Exploration ); précédent : 000009; suivant : 000011Shedding light on therapeutics in alopecia and their relevance to COVID-19.
Auteurs : Nicole Fagan [Irlande (pays)] ; Nekma Meah [Australie] ; Katherine York [Afrique du Sud] ; Laita Bokhari [Australie] ; Godfrey Fletcher [Irlande (pays)] ; Gang Chen [Australie] ; Desmond J. Tobin [Irlande (pays)] ; Andrew Messenger [Royaume-Uni] ; Alan D. Irvine [Irlande (pays)] ; Rodney Sinclair [Australie] ; Dmitri Wall [Irlande (pays)]Source :
- Clinics in dermatology [ 1879-1131 ]
Abstract
As of July 9, 2020, there were more than 12 million confirmed cases of coronavirus disease 2019 (COVID-19) across the globe, with more than 550,000 deaths. Many European countries, including Belgium, the United Kingdom, Italy, and Spain, have had the highest numbers of fatalities per capita. This indicates the potential for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus to overwhelm even the most advanced health care systems despite extreme societal interventions. Since its emergence, SARS-CoV-2 has disseminated across the globe, affecting the structure of global societies, infrastructure, and economies. Patients with alopecia are a diverse group who, for various indications, are prescribed a number of antimicrobials and antiandrogen treatments in addition to immunomodulatory therapies such as hydroxychloroquine, oral corticosteroids, and a range of broad immunosuppressants. These drugs are being scrutinized for their capacity to potentially affect SARS-CoV-2 outcomes. We examine these treatments and highlight the critical role that patient registries will play in generating real-world evidence to assess their impact on COVID-19 outcomes.
DOI: 10.1016/j.clindermatol.2020.12.015
PubMed: 33972056
PubMed Central: PMC7738938
Affiliations:
- Afrique du Sud, Australie, Irlande (pays), Royaume-Uni
- Leinster, Victoria (État)
- Dublin, Melbourne
- University College Dublin
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Shedding light on therapeutics in alopecia and their relevance to COVID-19.</title><author><name sortKey="Fagan, Nicole" sort="Fagan, Nicole" uniqKey="Fagan N" first="Nicole" last="Fagan">Nicole Fagan</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Trinity College Dublin, Dublin, Ireland. Electronic address: nifagan@tcd.ie.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>School of Medicine, Trinity College Dublin, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Meah, Nekma" sort="Meah, Nekma" uniqKey="Meah N" first="Nekma" last="Meah">Nekma Meah</name><affiliation wicri:level="3"><nlm:affiliation>Sinclair Dermatology, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sinclair Dermatology, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="York, Katherine" sort="York, Katherine" uniqKey="York K" first="Katherine" last="York">Katherine York</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Netcare Greenacres Hospital, Port Elizabeth, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Department of Dermatology, Netcare Greenacres Hospital, Port Elizabeth</wicri:regionArea><wicri:noRegion>Port Elizabeth</wicri:noRegion></affiliation></author><author><name sortKey="Bokhari, Laita" sort="Bokhari, Laita" uniqKey="Bokhari L" first="Laita" last="Bokhari">Laita Bokhari</name><affiliation wicri:level="3"><nlm:affiliation>Sinclair Dermatology, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sinclair Dermatology, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Fletcher, Godfrey" sort="Fletcher, Godfrey" uniqKey="Fletcher G" first="Godfrey" last="Fletcher">Godfrey Fletcher</name><affiliation wicri:level="4"><nlm:affiliation>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin</wicri:regionArea><orgName type="university">University College Dublin</orgName><placeName><settlement type="city">Dublin</settlement><region type="région" nuts="2">Leinster</region></placeName></affiliation></author><author><name sortKey="Chen, Gang" sort="Chen, Gang" uniqKey="Chen G" first="Gang" last="Chen">Gang Chen</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health Economics, Monash University, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Centre for Health Economics, Monash University, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Tobin, Desmond J" sort="Tobin, Desmond J" uniqKey="Tobin D" first="Desmond J" last="Tobin">Desmond J. Tobin</name><affiliation wicri:level="4"><nlm:affiliation>The Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>The Charles Institute of Dermatology, University College Dublin, Dublin</wicri:regionArea><orgName type="university">University College Dublin</orgName><placeName><settlement type="city">Dublin</settlement><region type="région" nuts="2">Leinster</region></placeName></affiliation></author><author><name sortKey="Messenger, Andrew" sort="Messenger, Andrew" uniqKey="Messenger A" first="Andrew" last="Messenger">Andrew Messenger</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Royal Hallamshire Hospital, Sheffield, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Dermatology, Royal Hallamshire Hospital, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Irvine, Alan D" sort="Irvine, Alan D" uniqKey="Irvine A" first="Alan D" last="Irvine">Alan D. Irvine</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Clinical Medicine, Trinity College Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Department of Dermatology, Clinical Medicine, Trinity College Dublin, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Sinclair, Rodney" sort="Sinclair, Rodney" uniqKey="Sinclair R" first="Rodney" last="Sinclair">Rodney Sinclair</name><affiliation wicri:level="3"><nlm:affiliation>Sinclair Dermatology, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sinclair Dermatology, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Wall, Dmitri" sort="Wall, Dmitri" uniqKey="Wall D" first="Dmitri" last="Wall">Dmitri Wall</name><affiliation wicri:level="4"><nlm:affiliation>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland; Hair Restoration Blackrock, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland; Hair Restoration Blackrock, Dublin</wicri:regionArea><orgName type="university">University College Dublin</orgName><placeName><settlement type="city">Dublin</settlement><region type="région" nuts="2">Leinster</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021 Jan-Feb</date><idno type="RBID">pubmed:33972056</idno><idno type="pmid">33972056</idno><idno type="doi">10.1016/j.clindermatol.2020.12.015</idno><idno type="pmc">PMC7738938</idno><idno type="wicri:Area/Main/Corpus">000035</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000035</idno><idno type="wicri:Area/Main/Curation">000035</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000035</idno><idno type="wicri:Area/Main/Exploration">000035</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Shedding light on therapeutics in alopecia and their relevance to COVID-19.</title><author><name sortKey="Fagan, Nicole" sort="Fagan, Nicole" uniqKey="Fagan N" first="Nicole" last="Fagan">Nicole Fagan</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Trinity College Dublin, Dublin, Ireland. Electronic address: nifagan@tcd.ie.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>School of Medicine, Trinity College Dublin, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Meah, Nekma" sort="Meah, Nekma" uniqKey="Meah N" first="Nekma" last="Meah">Nekma Meah</name><affiliation wicri:level="3"><nlm:affiliation>Sinclair Dermatology, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sinclair Dermatology, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="York, Katherine" sort="York, Katherine" uniqKey="York K" first="Katherine" last="York">Katherine York</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Netcare Greenacres Hospital, Port Elizabeth, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Department of Dermatology, Netcare Greenacres Hospital, Port Elizabeth</wicri:regionArea><wicri:noRegion>Port Elizabeth</wicri:noRegion></affiliation></author><author><name sortKey="Bokhari, Laita" sort="Bokhari, Laita" uniqKey="Bokhari L" first="Laita" last="Bokhari">Laita Bokhari</name><affiliation wicri:level="3"><nlm:affiliation>Sinclair Dermatology, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sinclair Dermatology, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Fletcher, Godfrey" sort="Fletcher, Godfrey" uniqKey="Fletcher G" first="Godfrey" last="Fletcher">Godfrey Fletcher</name><affiliation wicri:level="4"><nlm:affiliation>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin</wicri:regionArea><orgName type="university">University College Dublin</orgName><placeName><settlement type="city">Dublin</settlement><region type="région" nuts="2">Leinster</region></placeName></affiliation></author><author><name sortKey="Chen, Gang" sort="Chen, Gang" uniqKey="Chen G" first="Gang" last="Chen">Gang Chen</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Health Economics, Monash University, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Centre for Health Economics, Monash University, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Tobin, Desmond J" sort="Tobin, Desmond J" uniqKey="Tobin D" first="Desmond J" last="Tobin">Desmond J. Tobin</name><affiliation wicri:level="4"><nlm:affiliation>The Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>The Charles Institute of Dermatology, University College Dublin, Dublin</wicri:regionArea><orgName type="university">University College Dublin</orgName><placeName><settlement type="city">Dublin</settlement><region type="région" nuts="2">Leinster</region></placeName></affiliation></author><author><name sortKey="Messenger, Andrew" sort="Messenger, Andrew" uniqKey="Messenger A" first="Andrew" last="Messenger">Andrew Messenger</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Royal Hallamshire Hospital, Sheffield, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Dermatology, Royal Hallamshire Hospital, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Irvine, Alan D" sort="Irvine, Alan D" uniqKey="Irvine A" first="Alan D" last="Irvine">Alan D. Irvine</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Clinical Medicine, Trinity College Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Department of Dermatology, Clinical Medicine, Trinity College Dublin, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Sinclair, Rodney" sort="Sinclair, Rodney" uniqKey="Sinclair R" first="Rodney" last="Sinclair">Rodney Sinclair</name><affiliation wicri:level="3"><nlm:affiliation>Sinclair Dermatology, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sinclair Dermatology, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Wall, Dmitri" sort="Wall, Dmitri" uniqKey="Wall D" first="Dmitri" last="Wall">Dmitri Wall</name><affiliation wicri:level="4"><nlm:affiliation>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland; Hair Restoration Blackrock, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland; Hair Restoration Blackrock, Dublin</wicri:regionArea><orgName type="university">University College Dublin</orgName><placeName><settlement type="city">Dublin</settlement><region type="région" nuts="2">Leinster</region></placeName></affiliation></author></analytic><series><title level="j">Clinics in dermatology</title><idno type="eISSN">1879-1131</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">As of July 9, 2020, there were more than 12 million confirmed cases of coronavirus disease 2019 (COVID-19) across the globe, with more than 550,000 deaths. Many European countries, including Belgium, the United Kingdom, Italy, and Spain, have had the highest numbers of fatalities per capita. This indicates the potential for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus to overwhelm even the most advanced health care systems despite extreme societal interventions. Since its emergence, SARS-CoV-2 has disseminated across the globe, affecting the structure of global societies, infrastructure, and economies. Patients with alopecia are a diverse group who, for various indications, are prescribed a number of antimicrobials and antiandrogen treatments in addition to immunomodulatory therapies such as hydroxychloroquine, oral corticosteroids, and a range of broad immunosuppressants. These drugs are being scrutinized for their capacity to potentially affect SARS-CoV-2 outcomes. We examine these treatments and highlight the critical role that patient registries will play in generating real-world evidence to assess their impact on COVID-19 outcomes.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">33972056</PMID><DateRevised><Year>2021</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1131</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><MedlineDate>2021 Jan-Feb</MedlineDate></PubDate></JournalIssue><Title>Clinics in dermatology</Title><ISOAbbreviation>Clin Dermatol</ISOAbbreviation></Journal><ArticleTitle>Shedding light on therapeutics in alopecia and their relevance to COVID-19.</ArticleTitle><Pagination><MedlinePgn>76-83</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0738-081X(20)30250-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clindermatol.2020.12.015</ELocationID><Abstract><AbstractText>As of July 9, 2020, there were more than 12 million confirmed cases of coronavirus disease 2019 (COVID-19) across the globe, with more than 550,000 deaths. Many European countries, including Belgium, the United Kingdom, Italy, and Spain, have had the highest numbers of fatalities per capita. This indicates the potential for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus to overwhelm even the most advanced health care systems despite extreme societal interventions. Since its emergence, SARS-CoV-2 has disseminated across the globe, affecting the structure of global societies, infrastructure, and economies. Patients with alopecia are a diverse group who, for various indications, are prescribed a number of antimicrobials and antiandrogen treatments in addition to immunomodulatory therapies such as hydroxychloroquine, oral corticosteroids, and a range of broad immunosuppressants. These drugs are being scrutinized for their capacity to potentially affect SARS-CoV-2 outcomes. We examine these treatments and highlight the critical role that patient registries will play in generating real-world evidence to assess their impact on COVID-19 outcomes.</AbstractText><CopyrightInformation>Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fagan</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, Dublin, Ireland. Electronic address: nifagan@tcd.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meah</LastName><ForeName>Nekma</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sinclair Dermatology, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>York</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Netcare Greenacres Hospital, Port Elizabeth, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokhari</LastName><ForeName>Laita</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sinclair Dermatology, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Godfrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Health Economics, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobin</LastName><ForeName>Desmond J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>The Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messenger</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Royal Hallamshire Hospital, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irvine</LastName><ForeName>Alan D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Clinical Medicine, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>Rodney</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sinclair Dermatology, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wall</LastName><ForeName>Dmitri</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, University College Dublin, Dublin, Ireland; Hair Restoration Blackrock, Dublin, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Dermatol</MedlineTA><NlmUniqueID>8406412</NlmUniqueID><ISSNLinking>0738-081X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>11</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33972056</ArticleId><ArticleId IdType="pii">S0738-081X(20)30250-9</ArticleId><ArticleId IdType="doi">10.1016/j.clindermatol.2020.12.015</ArticleId><ArticleId IdType="pmc">PMC7738938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cancer Discov. 2014 Nov;4(11):1310-25</Citation><ArticleIdList><ArticleId IdType="pubmed">25122198</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2020 Jul;83(1):308-309</Citation><ArticleIdList><ArticleId IdType="pubmed">32283245</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2016 Dec;12(12):731-742</Citation><ArticleIdList><ArticleId IdType="pubmed">27784891</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Apr 7;323(13):1239-1242</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24841273</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2003 Oct;49(4):667-71</Citation><ArticleIdList><ArticleId IdType="pubmed">14512914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670</Citation><ArticleIdList><ArticleId IdType="pubmed">32196083</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2112-2125</Citation><ArticleIdList><ArticleId IdType="pubmed">29797431</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 May 26;10(5):e0127515</Citation><ArticleIdList><ArticleId IdType="pubmed">26010093</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2019 Jan;80(1):120-127.e2</Citation><ArticleIdList><ArticleId IdType="pubmed">30003990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1393-1397</Citation><ArticleIdList><ArticleId IdType="pubmed">30835851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):470-473</Citation><ArticleIdList><ArticleId IdType="pubmed">31986257</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dermatolog Treat. 2021 Mar;32(2):250-257</Citation><ArticleIdList><ArticleId IdType="pubmed">31389731</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Nurs. 1994 Aug;17(4):334-41</Citation><ArticleIdList><ArticleId IdType="pubmed">7525048</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychooncology. 2008 Apr;17(4):317-28</Citation><ArticleIdList><ArticleId IdType="pubmed">17721909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation><ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):930-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10365924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 29;395(10225):683-684</Citation><ArticleIdList><ArticleId IdType="pubmed">32122468</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Sep;3(9):e343</Citation><ArticleIdList><ArticleId IdType="pubmed">16968120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2005 Mar;152(3):466-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15787815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):e30-e31</Citation><ArticleIdList><ArticleId IdType="pubmed">32032529</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Sep 3;383(10):994</Citation><ArticleIdList><ArticleId IdType="pubmed">32649078</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2020 Aug;183(2):404-406</Citation><ArticleIdList><ArticleId IdType="pubmed">32348554</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 1995 Jul;70(7):628-33</Citation><ArticleIdList><ArticleId IdType="pubmed">7791384</ArticleId></ArticleIdList></Reference><Reference><Citation>Australas J Dermatol. 2007 Feb;48(1):43-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17222303</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2020 Jul;159(1):6-13.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">32272113</ArticleId></ArticleIdList></Reference><Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101663</Citation><ArticleIdList><ArticleId IdType="pubmed">32289548</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Clin Pharmacol. 2020 Jan;13(1):43-51</Citation><ArticleIdList><ArticleId IdType="pubmed">31865802</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2013 Aug;94(Pt 8):1749-1760</Citation><ArticleIdList><ArticleId IdType="pubmed">23620378</ArticleId></ArticleIdList></Reference><Reference><Citation>JCI Insight. 2016 Sep 22;1(15):e89776</Citation><ArticleIdList><ArticleId IdType="pubmed">27699252</ArticleId></ArticleIdList></Reference><Reference><Citation>Australas J Dermatol. 2019 May;60(2):163-170</Citation><ArticleIdList><ArticleId IdType="pubmed">30411329</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2015 Nov;40:71-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26365771</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2014 Apr;134(4):1141-1142</Citation><ArticleIdList><ArticleId IdType="pubmed">24202232</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2010 Mar;62(3):387-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20061052</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2020 Jun;20(6):355-362</Citation><ArticleIdList><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Today. 1992 Apr;13(4):136-42</Citation><ArticleIdList><ArticleId IdType="pubmed">1374612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2020 Apr;20(4):400-402</Citation><ArticleIdList><ArticleId IdType="pubmed">32113509</ArticleId></ArticleIdList></Reference><Reference><Citation>Intractable Rare Dis Res. 2016 Nov;5(4):314-315</Citation><ArticleIdList><ArticleId IdType="pubmed">27904832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatol Clin. 2013 Jan;31(1):129-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23159182</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2011 Nov;92(Pt 11):2542-2548</Citation><ArticleIdList><ArticleId IdType="pubmed">21752960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 May 22;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32450107</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2005 Aug 22;2:69</Citation><ArticleIdList><ArticleId IdType="pubmed">16115318</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2014 Feb 17;200(3):145</Citation><ArticleIdList><ArticleId IdType="pubmed">24528416</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2001 Mar;116(3):452-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11231320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2019 Jul 23;7:CD004477</Citation><ArticleIdList><ArticleId IdType="pubmed">31334568</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E587-E588</Citation><ArticleIdList><ArticleId IdType="pubmed">32297520</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2020 Jul;83(1):123-130</Citation><ArticleIdList><ArticleId IdType="pubmed">32165196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation><ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2017 Jun;69(6):1135-1143</Citation><ArticleIdList><ArticleId IdType="pubmed">28217930</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Obes (Lond). 2020 Aug;44(8):1790-1792</Citation><ArticleIdList><ArticleId IdType="pubmed">32409680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):473-475</Citation><ArticleIdList><ArticleId IdType="pubmed">32043983</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dermatol. 2005 Jul;141(7):847-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16027298</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2020 Nov;83(5):1478-1479</Citation><ArticleIdList><ArticleId IdType="pubmed">32213304</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cosmet Dermatol. 2020 Jul;19(7):1542-1543</Citation><ArticleIdList><ArticleId IdType="pubmed">32333494</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2020 Jul 1;180(7):934-943</Citation><ArticleIdList><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crit Care. 2020 Jun;57:279-283</Citation><ArticleIdList><ArticleId IdType="pubmed">32173110</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2010 Nov;177(5):2152-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20889564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation><ArticleIdList><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Dermatol. 2018 Jan;57(1):104-109</Citation><ArticleIdList><ArticleId IdType="pubmed">29231239</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eur Acad Dermatol Venereol. 2013 Dec;27(12):1461-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23531029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatol Ther. 2020 Jul;33(4):e13365</Citation><ArticleIdList><ArticleId IdType="pubmed">32237190</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767</Citation><ArticleIdList><ArticleId IdType="pubmed">29161116</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2018 Jan;78(1):15-24</Citation><ArticleIdList><ArticleId IdType="pubmed">29241773</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2014 Apr;70(4):670-678</Citation><ArticleIdList><ArticleId IdType="pubmed">24508293</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Endocrinol. 2015;2015:298107</Citation><ArticleIdList><ArticleId IdType="pubmed">26421011</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Australas J Dermatol. 2011 May;52(2):132-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21605098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Afrique du Sud</li><li>Australie</li><li>Irlande (pays)</li><li>Royaume-Uni</li></country><region><li>Leinster</li><li>Victoria (État)</li></region><settlement><li>Dublin</li><li>Melbourne</li></settlement><orgName><li>University College Dublin</li></orgName></list><tree><country name="Irlande (pays)"><noRegion><name sortKey="Fagan, Nicole" sort="Fagan, Nicole" uniqKey="Fagan N" first="Nicole" last="Fagan">Nicole Fagan</name></noRegion><name sortKey="Fletcher, Godfrey" sort="Fletcher, Godfrey" uniqKey="Fletcher G" first="Godfrey" last="Fletcher">Godfrey Fletcher</name><name sortKey="Irvine, Alan D" sort="Irvine, Alan D" uniqKey="Irvine A" first="Alan D" last="Irvine">Alan D. Irvine</name><name sortKey="Tobin, Desmond J" sort="Tobin, Desmond J" uniqKey="Tobin D" first="Desmond J" last="Tobin">Desmond J. Tobin</name><name sortKey="Wall, Dmitri" sort="Wall, Dmitri" uniqKey="Wall D" first="Dmitri" last="Wall">Dmitri Wall</name></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Meah, Nekma" sort="Meah, Nekma" uniqKey="Meah N" first="Nekma" last="Meah">Nekma Meah</name></region><name sortKey="Bokhari, Laita" sort="Bokhari, Laita" uniqKey="Bokhari L" first="Laita" last="Bokhari">Laita Bokhari</name><name sortKey="Chen, Gang" sort="Chen, Gang" uniqKey="Chen G" first="Gang" last="Chen">Gang Chen</name><name sortKey="Sinclair, Rodney" sort="Sinclair, Rodney" uniqKey="Sinclair R" first="Rodney" last="Sinclair">Rodney Sinclair</name></country><country name="Afrique du Sud"><noRegion><name sortKey="York, Katherine" sort="York, Katherine" uniqKey="York K" first="Katherine" last="York">Katherine York</name></noRegion></country><country name="Royaume-Uni"><noRegion><name sortKey="Messenger, Andrew" sort="Messenger, Andrew" uniqKey="Messenger A" first="Andrew" last="Messenger">Andrew Messenger</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000010 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000010 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33972056
|texte= Shedding light on therapeutics in alopecia and their relevance to COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33972056" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |